VCIM
PRAX icon

Velan Capital Investment Management’s Praxis Precision Medicines PRAX Stock Holding History

Velan Capital Investment Management’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$32.5M Hold
100,781
– – 20.34% 1
2025
Q4 		$29.7M Sell
100,781
-32,024
-24% -$5.96M 17.23% 1
2025
Q3 		$7.04M Sell
132,805
-16,529
-11% -$801K 6.61% 5
2025
Q2 		$6.28M Sell
149,334
-35,666
-19% -$1.36M 6.2% 7
2025
Q1 		$7.01M Sell
185,000
-115,000
-38% -$7.18M 7.21% 5
2024
Q4 		$23.1M Sell
300,000
-50,666
-14% -$3.67M 19.92% 2
2024
Q3 		$20.2M Hold
350,666
– – 18.87% 2
2024
Q2 		$14.5M Hold
350,666
– – 8.31% 4
2024
Q1 		$21.4M Buy
350,666
+5,000
+1% +$224K 9.72% 3
2023
Q4 		$7.7M Sell
345,666
-1
-0% -$18 4.5% 7
2023
Q3 		$8.87M Hold
345,667
– – 7.15% 2
2023
Q2 		$5.96M Hold
345,667
– – 5.54% 5
2023
Q1 		$4.19M Buy
+345,667
New +$14.6M 3.58% 10

Other funds holding PRAX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Velan Capital Investment Management's PRAX Position: Q1 2026 in Review

Velan Capital Investment Management held its Praxis Precision Medicines (PRAX) position steady in Q1 2026 at 100,781 shares worth $32.5M. The position accounts for 20.34% of the portfolio, ranked #1.

Velan Capital Investment Management first reported a position in PRAX in Q1 2023 and has held it in 13 quarters since. 289 funds tracked by Wall St. Rank hold PRAX as of Q1 2026.

  • Velan Capital Investment Management held 100,781 shares of Praxis Precision Medicines worth $32.5M as of Q1 2026.
  • Velan Capital Investment Management left its Praxis Precision Medicines share count unchanged in Q1 2026.
  • Praxis Precision Medicines made up 20.34% of Velan Capital Investment Management's portfolio in Q1 2026, its #1 holding.
  • Velan Capital Investment Management first reported a position in Praxis Precision Medicines in Q1 2023 and has held it in 13 quarters since.
  • 289 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q1 2026.

Based on Velan Capital Investment Management's 13F filing for Q1 2026, filed 15 May 2026.